Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Breast Dynamic Contrast-enhanced-magnetic Resonance Imaging And Radiomics: State Of Art

Alessia Angela Maria Orlando, M. Dimarco, R. Cannella, T. V. Bartolotta
Published 2020 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
This paper references
10.1148/RADIOL.2016152110
MR Imaging Radiomics Signatures for Predicting the Risk of Breast Cancer Recurrence as Given by Research Versions of MammaPrint, Oncotype DX, and PAM50 Gene Assays.
H. Li (2016)
10.21147/j.issn.1000-9604.2018.04.06
A radiomic nomogram based on an apparent diffusion coefficient map for differential diagnosis of suspicious breast findings
B. Hu (2018)
10.1002/jmri.24884
MRI phenotype of breast cancer: Kinetic assessment for molecular subtypes
Eric M Blaschke (2015)
10.2214/AJR.09.3908
Accuracy of MRI in prediction of pathologic complete remission in breast cancer after preoperative therapy: a meta-analysis.
Y. Yuan (2010)
10.1016/j.clbc.2016.11.004
Magnetic Resonance Imaging for Axillary Breast Cancer Metastasis in the Neoadjuvant Setting: A Prospective Study
Anne E Mattingly (2017)
10.1245/s10434-018-6613-4
Predicting Post Neoadjuvant Axillary Response Using a Novel Convolutional Neural Network Algorithm
R. Ha (2018)
10.3322/caac.21551
Cancer statistics, 2019
R. Siegel (2019)
10.1002/mp.12453
A deep feature fusion methodology for breast cancer diagnosis demonstrated on three imaging modality datasets
Natalia Antropova (2017)
10.1259/bjr.20190948
Radiomics: from qualitative to quantitative imaging.
W. Rogers (2020)
10.1016/j.ejrad.2019.108736
Exploring breast cancer response prediction to neoadjuvant systemic therapy using MRI-based radiomics: A systematic review.
R. Granzier (2019)
10.1007/s00330-018-5981-2
Radiomic nomogram for prediction of axillary lymph node metastasis in breast cancer
Lu Han (2018)
10.1186/s13058-019-1187-z
Radiomic signatures with contrast-enhanced magnetic resonance imaging for the assessment of breast cancer receptor status and molecular subtypes: initial results
D. Leithner (2019)
10.3389/fonc.2019.00980
Radiomics Analysis of Dynamic Contrast-Enhanced Magnetic Resonance Imaging for the Prediction of Sentinel Lymph Node Metastasis in Breast Cancer
J. Liu (2019)
10.1002/jmri.26244
Convolutional Neural Network Using a Breast MRI Tumor Dataset Can Predict Oncotype Dx Recurrence Score
R. Ha (2019)
10.1093/ANNONC/MDS324
Neoadjuvant treatment of breast cancer.
A. Thompson (2012)
10.1148/radiol.2015151169
Radiomics: Images Are More than Pictures, They Are Data
R. Gillies (2016)
10.1007/s00432-018-2595-7
A study of association of Oncotype DX recurrence score with DCE-MRI characteristics using multivariate machine learning models
Ashirbani Saha (2018)
10.1016/j.breast.2019.10.018
Overview of radiomics in breast cancer diagnosis and prognostication
A. Tagliafico (2019)
10.1038/s41523-017-0045-3
Integrated radiomic framework for breast cancer and tumor biology using advanced machine learning and multiparametric MRI
V. Parekh (2017)
10.1155/2018/2610801
Use of Quantitative Morphological and Functional Features for Assessment of Axillary Lymph Node in Breast Dynamic Contrast-Enhanced Magnetic Resonance Imaging
R. Fusco (2018)
10.1371/journal.pone.0171683
Radiomic analysis reveals DCE-MRI features for prediction of molecular subtypes of breast cancer
Ming Fan (2017)
10.1148/radiol.12110748
Locally advanced breast cancer: MR imaging for prediction of response to neoadjuvant chemotherapy--results from ACRIN 6657/I-SPY TRIAL.
N. Hylton (2012)
10.1007/s00330-012-2403-8
Correlations between diffusion-weighted imaging and breast cancer biomarkers
L. Martincich (2012)
10.1109/JBHI.2019.2956351
Joint Prediction of Breast Cancer Histological Grade and Ki-67 Expression Level Based on DCE-MRI and DWI Radiomics
M. Fan (2020)
10.1016/j.crad.2018.05.027
Breast cancer Ki67 expression prediction by DCE-MRI radiomics features.
W. Ma (2018)
10.1245/s10434-009-0606-2
Presenting Features of Breast Cancer Differ by Molecular Subtype
L. Wiechmann (2009)
10.1007/s00268-019-05032-9
MRI Performance in Detecting pCR After Neoadjuvant Chemotherapy by Molecular Subtype of Breast Cancer
N. Yu (2019)
10.1158/1078-0432.CCR-18-3190
Radiomics of Multiparametric MRI for Pretreatment Prediction of Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer: A Multicenter Study
Z. Liu (2019)
10.1109/CBMS.2012.6266312
Segmentation and classification of breast lesions using dynamic and textural features in Dynamic Contrast Enhanced-Magnetic Resonance Imaging
R. Fusco (2012)
10.1007/s12094-019-02109-8
Multiparametric MRI-based radiomics analysis for prediction of breast cancers insensitive to neoadjuvant chemotherapy
Qianqian Xiong (2019)
10.1002/nbm.3132
Dynamic contrast‐enhanced MRI texture analysis for pretreatment prediction of clinical and pathological response to neoadjuvant chemotherapy in patients with locally advanced breast cancer
J. R. Teruel (2014)
10.1002/mrm.22800
Combined use of T2‐weighted MRI and T1‐weighted dynamic contrast–enhanced MRI in the automated analysis of breast lesions
N. Bhooshan (2011)
10.1186/s12880-017-0239-z
MRI texture analysis in differentiating luminal A and luminal B breast cancer molecular subtypes - a feasibility study
K. Holli-Helenius (2017)
10.2214/AJR.11.7292
Evaluation of breast cancer using proton MR spectroscopy: total choline peak integral and signal-to-noise ratio as prognostic indicators.
H. J. Shin (2012)
10.1007/s00330-016-4235-4
Preoperative axillary lymph node evaluation in breast cancer patients by breast magnetic resonance imaging (MRI): Can breast MRI exclude advanced nodal disease?
S. Hyun (2016)
10.1155/2019/4731532
Texture Analysis of Dynamic Contrast-Enhanced MRI in Evaluating Pathologic Complete Response (pCR) of Mass-Like Breast Cancer after Neoadjuvant Therapy
K. Cao (2019)
10.1002/jmri.26732
Characterization of Sub‐1 cm Breast Lesions Using Radiomics Analysis
P. Gibbs (2019)
10.1148/radiol.2016160261
Breast Cancer Heterogeneity: MR Imaging Texture Analysis and Survival Outcomes.
J. Kim (2017)
10.1200/JCO.2015.65.2289
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline.
Lyndsay N. Harris (2016)
10.1002/jmri.26852
Machine learning in breast MRI
B. Reig (2019)
10.1002/jmri.26224
Preoperative prediction of sentinel lymph node metastasis in breast cancer by radiomic signatures from dynamic contrast‐enhanced MRI
C. Liu (2019)
10.1002/jmri.25712
Computer‐aided heterogeneity analysis in breast MR imaging assessment of ductal carcinoma in situ: Correlating histologic grade and receptor status
S. S. Chou (2017)
10.1007/s00330-011-2319-8
Tumour heterogeneity in non-small cell lung carcinoma assessed by CT texture analysis: a potential marker of survival
B. Ganeshan (2011)
10.1200/JCO.2004.00.4960
Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer.
C. Kuhl (2005)
10.1148/radiol.2017170273
Radiomics Based on Adapted Diffusion Kurtosis Imaging Helps to Clarify Most Mammographic Findings Suspicious for Cancer.
S. Bickelhaupt (2018)
10.1067/j.cpradiol.2018.08.003
Relationships Between Human-Extracted MRI Tumor Phenotypes of Breast Cancer and Clinical Prognostic Indicators Including Receptor Status and Molecular Subtype.
J. Net (2018)
10.1016/j.acra.2008.06.005
Quantitative analysis of lesion morphology and texture features for diagnostic prediction in breast MRI.
K. Nie (2008)
10.1186/s12885-015-1563-8
Texture analysis on MR images helps predicting non-response to NAC in breast cancer
N. Michoux (2015)
10.1002/cncr.29791
Using computer‐extracted image phenotypes from tumors on breast magnetic resonance imaging to predict breast cancer pathologic stage
E. Burnside (2016)
10.1007/s11547-019-01100-1
Invasive ductal breast cancer: preoperative predict Ki-67 index based on radiomics of ADC maps
Y. Zhang (2019)
10.1097/RCT.0000000000000978
Combining Dynamic Contrast-Enhanced Magnetic Resonance Imaging and Apparent Diffusion Coefficient Maps for a Radiomics Nomogram to Predict Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer Patients
X. Chen (2020)
10.1038/s41598-020-60822-9
MRI Radiomic Features: Association with Disease-Free Survival in Patients with Triple-Negative Breast Cancer
S. Kim (2020)
10.1016/j.ejrad.2014.12.003
Using quantitative image analysis to classify axillary lymph nodes on breast MRI: a new application for the Z 0011 Era.
David V Schacht (2015)
10.1177/0284185117690421
Diagnostic performance of breast ultrasonography and MRI in the prediction of lymph node status after neoadjuvant chemotherapy for breast cancer
Su Min Ha (2017)
10.1007/s10549-018-4990-9
Multivariate machine learning models for prediction of pathologic response to neoadjuvant therapy in breast cancer using MRI features: a study using an independent validation set
E. Cain (2018)
10.1016/j.acra.2019.11.004
Preoperative Prediction of Axillary Lymph Node Metastasis in Breast Carcinoma Using Radiomics Features Based on the Fat-Suppressed T2 Sequence.
H. Tan (2019)
10.1002/mrm.24117
Association of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 status with total choline concentration and tumor volume in breast cancer patients: An MRI and in vivo proton MRS study
R. G. Sah (2012)
10.1186/s13058-017-0846-1
Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI
Nathaniel Braman (2017)
10.1186/s12885-020-6523-2
Predicting the response to neoadjuvant chemotherapy for breast cancer: wavelet transforming radiomics in MRI
J. Zhou (2020)
10.1016/j.mri.2016.03.001
Quantification of breast tumor heterogeneity for ER status, HER2 status, and TN molecular subtype evaluation on DCE-MRI.
R. Chang (2016)
10.1038/s41598-019-38502-0
Preoperative Prediction of Axillary Lymph Node Metastasis in Breast Cancer using Radiomics Features of DCE-MRI
Xiaoyu Cui (2019)
10.5405/jmbe.1183
Classification of Small Lesions in Breast MRI: Evaluating The Role of Dynamically Extracted Texture Features Through Feature Selection.
Mahesh B. Nagarajan (2013)
10.1002/jmri.25661
Identifying relations between imaging phenotypes and molecular subtypes of breast cancer: Model discovery and external validation
J. Wu (2017)
10.1111/tbj.12799
Relationships Between MRI Breast Imaging‐Reporting and Data System (BI‐RADS) Lexicon Descriptors and Breast Cancer Molecular Subtypes: Internal Enhancement is Associated with Luminal B Subtype
L. Grimm (2017)
10.1038/npjbcancer.2016.12
Quantitative MRI radiomics in the prediction of molecular classifications of breast cancer subtypes in the TCGA/TCIA data set
H. Li (2016)
10.1136/amiajnl-2012-001460
Research and applications: Dynamic contrast-enhanced MRI-based biomarkers of therapeutic response in triple-negative breast cancer
D. I. Golden (2013)
10.1186/s41747-018-0068-z
Radiomics: the facts and the challenges of image analysis
S. Rizzo (2018)
10.1002/jmri.26688
Preoperative prediction of lymphovascular invasion in invasive breast cancer with dynamic contrast‐enhanced‐MRI‐based radiomics
Zhuangsheng Liu (2019)
10.1093/annonc/mdr304
Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
A. Goldhirsch (2011)
10.1093/annonc/mds586
Molecular subclasses of breast cancer: how do we define them? The IMPAKT 2012 Working Group Statement.
S. Guiu (2012)
10.1016/j.acra.2018.01.006
An MRI-based Radiomics Classifier for Preoperative Prediction of Ki-67 Status in Breast Cancer.
Cuishan Liang (2018)
10.4103/jcrt.JCRT_678_17
Meta-analysis of diagnostic accuracy of magnetic resonance imaging and mammography for breast cancer.
Y. Zhang (2017)
10.3322/caac.21393
Breast Cancer—Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual
A. Giuliano (2017)
10.1016/j.acra.2009.08.012
Characterization of breast cancer types by texture analysis of magnetic resonance images.
K. Holli (2010)
10.1002/jmri.26981
Diagnosis of Benign and Malignant Breast Lesions on DCE‐MRI by Using Radiomics and Deep Learning With Consideration of Peritumor Tissue
J. Zhou (2019)
10.1148/radiol.14121031
Computerized image analysis for identifying triple-negative breast cancers and differentiating them from other molecular subtypes of breast cancer on dynamic contrast-enhanced MR images: a feasibility study.
S. Agner (2014)
10.1158/1078-0432.CCR-17-3783
Radiomics Signature on Magnetic Resonance Imaging: Association with Disease-Free Survival in Patients with Invasive Breast Cancer
Hyunjin Park (2018)
10.1186/s41747-019-0141-2
Textural radiomic features and time-intensity curve data analysis by dynamic contrast-enhanced MRI for early prediction of breast cancer therapy response: preliminary data
R. Fusco (2020)
10.1038/s41598-020-59923-2
Three-dimensional radiomics of triple-negative breast cancer: Prediction of systemic recurrence
Jieun Koh (2020)
10.5306/wjco.v5.i2.61
Magnetic resonance imaging in breast cancer: A literature review and future perspectives.
G. L. Menezes (2014)
10.3892/ol.2018.9271
Correlation between DCE-MRI radiomics features and Ki-67 expression in invasive breast cancer
M. Juan (2018)
10.1001/jamanetworkopen.2019.2561
Association of Peritumoral Radiomics With Tumor Biology and Pathologic Response to Preoperative Targeted Therapy for HER2 (ERBB2)–Positive Breast Cancer
Nathaniel Braman (2019)
10.1093/jnci/djs528
Meta-analysis of magnetic resonance imaging in detecting residual breast cancer after neoadjuvant therapy.
M. L. Marinovich (2013)
10.1002/jmri.25606
Prediction of malignancy by a radiomic signature from contrast agent‐free diffusion MRI in suspicious breast lesions found on screening mammography.
S. Bickelhaupt (2017)
10.1186/1472-6890-13-31
The relationship between lymphovascular invasion and angiogenesis, hormone receptors, cell proliferation and survival in patients with primary operable invasive ductal breast cancer
Z. M. Mohammed (2013)
10.1148/radiol.2018172462
Intratumoral Spatial Heterogeneity at Perfusion MR Imaging Predicts Recurrence-free Survival in Locally Advanced Breast Cancer Treated with Neoadjuvant Chemotherapy.
J. Wu (2018)
10.1007/s10549-018-4801-3
Response rates and pathologic complete response by breast cancer molecular subtype following neoadjuvant chemotherapy
W. Haque (2018)
10.1159/000499931
St. Gallen/Vienna 2019: A Brief Summary of the Consensus Discussion on the Optimal Primary Breast Cancer Treatment
M. Balic (2019)
10.1371/journal.pone.0143308
Identifying Triple-Negative Breast Cancer Using Background Parenchymal Enhancement Heterogeneity on Dynamic Contrast-Enhanced MRI: A Pilot Radiomics Study
J. Wang (2015)
10.1148/radiol.14130569
Changes in primary breast cancer heterogeneity may augment midtreatment MR imaging assessment of response to neoadjuvant chemotherapy.
Jyoti K. Parikh (2014)
10.1002/jmri.25119
Breast cancer molecular subtype classifier that incorporates MRI features
E. Sutton (2016)
10.1002/jmri.25501
Separation of benign and malignant breast lesions using dynamic contrast enhanced MRI in a biopsy cohort
S. Kim (2017)
10.1007/s10278-018-0144-1
Prior to Initiation of Chemotherapy, Can We Predict Breast Tumor Response? Deep Learning Convolutional Neural Networks Approach Using a Breast MRI Tumor Dataset
R. Ha (2018)
10.1007/s00330-017-5005-7
Preoperative prediction of sentinel lymph node metastasis in breast cancer based on radiomics of T2-weighted fat-suppression and diffusion-weighted MRI
Y. Dong (2017)
10.1093/annonc/mdt303
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
A. Goldhirsch (2013)
10.1016/j.ejrad.2018.09.024
Is there a correlation between 3T multiparametric MRI and molecular subtypes of breast cancer?
S. Montemezzi (2018)
10.1007/s00330-015-3845-6
Magnetic resonance imaging texture analysis classification of primary breast cancer
S. Waugh (2015)
10.2325/JBCS.13.64
Rim enhancement of breast cancers on contrast-enhanced MR imaging: Relationship with prognostic factors
M. Jinguji (2006)
10.1148/radiol.14131375
Identification of intrinsic imaging phenotypes for breast cancer tumors: preliminary associations with gene expression profiles.
A. Ashraf (2014)
10.1067/j.cpradiol.2019.07.003
The Relationship Between MRI Findings and Molecular Subtypes in Women With Breast Cancer.
V. Öztürk (2019)
10.18383/j.tom.2016.00241
DCE-MRI Texture Features for Early Prediction of Breast Cancer Therapy Response
G. Thibault (2017)
10.1007/s10278-018-0086-7
Axillary Lymph Node Evaluation Utilizing Convolutional Neural Networks Using MRI Dataset
R. Ha (2018)
10.1002/mrm.10496
Textural analysis of contrast‐enhanced MR images of the breast
P. Gibbs (2003)
10.1007/s10549-018-4675-4
Rapid review: radiomics and breast cancer
F. Valdora (2018)
10.1002/jmri.27098
Radiomics Based on Multimodal MRI for the Differential Diagnosis of Benign and Malignant Breast Lesions
Q. Zhang (2020)



Semantic Scholar Logo Some data provided by SemanticScholar